Sivik Global Healthcare’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-150,000
Closed -$4.6M 50
2020
Q4
$4.6M Buy
+150,000
New +$4.58M 1.88% 32
2019
Q3
Sell
-150,000
Closed -$5.07M 49
2019
Q2
$5.07M Sell
150,000
-25,000
-14% -$812K 1.23% 23
2019
Q1
$5.61M Buy
175,000
+91,363
+109% +$2.81M 2.07% 21
2018
Q4
$2.64M Buy
+83,637
New +$2.74M 1.42% 34

Other funds holding ELAN

Sivik Global Healthcare's ELAN Position: Q1 2021 in Review

Sivik Global Healthcare sold out of Elanco Animal Health (ELAN) in Q1 2021, closing a stake of 150,000 shares — an estimated $4.6M sold.

Sivik Global Healthcare first reported a position in ELAN in Q4 2018 and held it in 4 quarters. The position peaked at $5.61M in Q1 2019. 449 funds tracked by Wall St. Rank hold ELAN as of Q1 2021.

  • Sivik Global Healthcare reported no remaining Elanco Animal Health position as of Q1 2021 after selling out during the quarter.
  • Sivik Global Healthcare sold 150,000 Elanco Animal Health shares in Q1 2021, an estimated $4.6M.
  • Sivik Global Healthcare first reported a position in Elanco Animal Health in Q4 2018 and held it in 4 quarters.
  • Sivik Global Healthcare's Elanco Animal Health position peaked at $5.61M in Q1 2019.
  • 449 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2021.

Based on Sivik Global Healthcare's 13F filing for Q1 2021, filed 12 May 2021.